KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInventory AverageInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Teva Pharmaceutical Industries (TEVA) Return on Sales: 2009-2024

Historic Return on Sales for Teva Pharmaceutical Industries (TEVA) over the last 16 years, with Dec 2024 value amounting to -0.12%.

  • Teva Pharmaceutical Industries' Return on Sales rose 19.00% to 0.04% in Q3 2025 from the same period last year, while for Sep 2025 it was 0.04%, marking a year-over-year increase of 19.00%. This contributed to the annual value of -0.12% for FY2024, which is 8.00% down from last year.
  • Per Teva Pharmaceutical Industries' latest filing, its Return on Sales stood at -0.12% for FY2024, which was down 204.26% from -0.04% recorded in FY2023.
  • Teva Pharmaceutical Industries' Return on Sales' 5-year high stood at 0.03% during FY2021, with a 5-year trough of -0.25% in FY2020.
  • Its 3-year average for Return on Sales is -0.11%, with a median of -0.12% in 2024.
  • In the last 5 years, Teva Pharmaceutical Industries' Return on Sales declined by 20bps in 2020 and then climbed by 28bps in 2021.
  • Over the past 5 years, Teva Pharmaceutical Industries' Return on Sales (Yearly) stood at -0.25% in 2020, then rose by 28bps to 0.03% in 2021, then dropped by 20bps to -0.17% in 2022, then climbed by 13bps to -0.04% in 2023, then fell by 8bps to -0.12% in 2024.